<DOC>
	<DOCNO>NCT01791413</DOCNO>
	<brief_summary>The purpose study evaluate ovarian reserve change preoperative depot medroxyprogesterone acetate ( DMPA ) woman ovarian endometrioma undergo laparoscopic cystectomy .</brief_summary>
	<brief_title>Effect Pre-operative Depo Medroxyprogesterone Acetate Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy Endometriomas</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>Healthy woman 1840 year old A diagnosis endometrioma diameter least 3 cm . Candidates laparoscopic cystectomy Patients ' refusal participate Not candidate depot medroxyprogesterone acetate : cirrhosis , chronic kidney disease , venous thrombosis Use estrogensuppressive drug precede 3 month , : Oral contraceptive , GnRH analogues , Progestins , Danazol Pathology report present endometriosis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>